Literature DB >> 27020099

Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases.

Lluís Ballell1, Mike Strange1, Nicholas Cammack1, Alan H Fairlamb2, Leszek Borysiewicz3.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27020099     DOI: 10.1038/nrd.2016.51

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  9 in total

1.  Thousands of chemical starting points for antimalarial lead identification.

Authors:  Francisco-Javier Gamo; Laura M Sanz; Jaume Vidal; Cristina de Cozar; Emilio Alvarez; Jose-Luis Lavandera; Dana E Vanderwall; Darren V S Green; Vinod Kumar; Samiul Hasan; James R Brown; Catherine E Peishoff; Lon R Cardon; Jose F Garcia-Bustos
Journal:  Nature       Date:  2010-05-20       Impact factor: 49.962

Review 2.  Hit and lead criteria in drug discovery for infectious diseases of the developing world.

Authors:  Kei Katsuno; Jeremy N Burrows; Ken Duncan; Rob Hooft van Huijsduijnen; Takushi Kaneko; Kiyoshi Kita; Charles E Mowbray; Dennis Schmatz; Peter Warner; B T Slingsby
Journal:  Nat Rev Drug Discov       Date:  2015-10-05       Impact factor: 84.694

3.  3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential.

Authors:  Yassir Younis; Frederic Douelle; Tzu-Shean Feng; Diego González Cabrera; Claire Le Manach; Aloysius T Nchinda; Sandra Duffy; Karen L White; David M Shackleford; Julia Morizzi; Janne Mannila; Kasiram Katneni; Ravi Bhamidipati; K Mohammed Zabiulla; Jayan T Joseph; Sridevi Bashyam; David Waterson; Michael J Witty; David Hardick; Sergio Wittlin; Vicky Avery; Susan A Charman; Kelly Chibale
Journal:  J Med Chem       Date:  2012-03-21       Impact factor: 7.446

4.  A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria.

Authors:  Margaret A Phillips; Julie Lotharius; Kennan Marsh; John White; Anthony Dayan; Karen L White; Jacqueline W Njoroge; Farah El Mazouni; Yanbin Lao; Sreekanth Kokkonda; Diana R Tomchick; Xiaoyi Deng; Trevor Laird; Sangeeta N Bhatia; Sandra March; Caroline L Ng; David A Fidock; Sergio Wittlin; Maria Lafuente-Monasterio; Francisco Javier Gamo Benito; Laura Maria Sanz Alonso; Maria Santos Martinez; Maria Belen Jimenez-Diaz; Santiago Ferrer Bazaga; Iñigo Angulo-Barturen; John N Haselden; James Louttit; Yi Cui; Arun Sridhar; Anna-Marie Zeeman; Clemens Kocken; Robert Sauerwein; Koen Dechering; Vicky M Avery; Sandra Duffy; Michael Delves; Robert Sinden; Andrea Ruecker; Kristina S Wickham; Rosemary Rochford; Janet Gahagen; Lalitha Iyer; Ed Riccio; Jon Mirsalis; Ian Bathhurst; Thomas Rueckle; Xavier Ding; Brice Campo; Didier Leroy; M John Rogers; Pradipsinh K Rathod; Jeremy N Burrows; Susan A Charman
Journal:  Sci Transl Med       Date:  2015-07-15       Impact factor: 17.956

5.  A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.

Authors:  Maria Jesus Almela; Sonia Lozano; Joël Lelièvre; Gonzalo Colmenarejo; José Miguel Coterón; Janneth Rodrigues; Carolina Gonzalez; Esperanza Herreros
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

6.  New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.

Authors:  Imanol Peña; M Pilar Manzano; Juan Cantizani; Albane Kessler; Julio Alonso-Padilla; Ana I Bardera; Emilio Alvarez; Gonzalo Colmenarejo; Ignacio Cotillo; Irene Roquero; Francisco de Dios-Anton; Vanessa Barroso; Ana Rodriguez; David W Gray; Miguel Navarro; Vinod Kumar; Alexander Sherstnev; David H Drewry; James R Brown; Jose M Fiandor; J Julio Martin
Journal:  Sci Rep       Date:  2015-03-05       Impact factor: 4.379

7.  THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria.

Authors:  Jonathan A G Cox; Katherine A Abrahams; Carlos Alemparte; Sonja Ghidelli-Disse; Joaquín Rullas; Iñigo Angulo-Barturen; Albel Singh; Sudagar S Gurcha; Vijayashankar Nataraj; Stephen Bethell; Modesto J Remuiñán; Lourdes Encinas; Peter J Jervis; Nicholas C Cammack; Apoorva Bhatt; Ulrich Kruse; Marcus Bantscheff; Klaus Fütterer; David Barros; Lluis Ballell; Gerard Drewes; Gurdyal S Besra
Journal:  Nat Microbiol       Date:  2016-01-18       Impact factor: 17.745

8.  Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis.

Authors:  Lluís Ballell; Robert H Bates; Rob J Young; Daniel Alvarez-Gomez; Emilio Alvarez-Ruiz; Vanessa Barroso; Delia Blanco; Benigno Crespo; Jaime Escribano; Rubén González; Sonia Lozano; Sophie Huss; Angel Santos-Villarejo; José Julio Martín-Plaza; Alfonso Mendoza; María José Rebollo-Lopez; Modesto Remuiñan-Blanco; José Luis Lavandera; Esther Pérez-Herran; Francisco Javier Gamo-Benito; José Francisco García-Bustos; David Barros; Julia P Castro; Nicholas Cammack
Journal:  ChemMedChem       Date:  2013-01-10       Impact factor: 3.466

9.  Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB.

Authors:  Katherine A Abrahams; Jonathan A G Cox; Vickey L Spivey; Nicholas J Loman; Mark J Pallen; Chrystala Constantinidou; Raquel Fernández; Carlos Alemparte; Modesto J Remuiñán; David Barros; Lluis Ballell; Gurdyal S Besra
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  9 in total
  6 in total

1.  Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease.

Authors:  Irene Roquero; Juan Cantizani; Ignacio Cotillo; M Pilar Manzano; Albane Kessler; J Julio Martín; Case W McNamara
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-05-22       Impact factor: 4.077

2.  The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp.

Authors:  Elena Fernández Álvaro; Phat Voong Vinh; Cristina de Cozar; David R Willé; Beatriz Urones; Alvaro Cortés; Alan Price; Nhu Tran Do Hoang; Tuyen Ha Thanh; Molly McCloskey; Shareef Shaheen; Denise Dayao; Amanda Martinot; Jaime de Mercado; Pablo Castañeda; Adolfo García-Perez; Benson Singa; Patricia Pavlinac; Judd Walson; Maria Santos Martínez-Martínez; Samuel L M Arnold; Saul Tzipori; Lluis Ballell Pages; Stephen Baker
Journal:  Elife       Date:  2022-03-15       Impact factor: 8.713

3.  Repurposing clinically approved cephalosporins for tuberculosis therapy.

Authors:  Santiago Ramón-García; Rubén González Del Río; Angel Santos Villarejo; Gaye D Sweet; Fraser Cunningham; David Barros; Lluís Ballell; Alfonso Mendoza-Losana; Santiago Ferrer-Bazaga; Charles J Thompson
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

Review 4.  Innovation in neglected tropical disease drug discovery and development.

Authors:  Hong-Bo Weng; Hai-Xia Chen; Ming-Wei Wang
Journal:  Infect Dis Poverty       Date:  2018-06-18       Impact factor: 4.520

Review 5.  New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story.

Authors:  Emily A Dickie; Federica Giordani; Matthew K Gould; Pascal Mäser; Christian Burri; Jeremy C Mottram; Srinivasa P S Rao; Michael P Barrett
Journal:  Trop Med Infect Dis       Date:  2020-02-19

6.  Evaluation of Novel Chalcone-Thiosemicarbazones Derivatives as Potential Anti-Leishmania amazonensis Agents and Its HSA Binding Studies.

Authors:  Edinéia Pastro Mendes; Carla Marins Goulart; Otávio Augusto Chaves; Viviane Dos S Faiões; Marilene M Canto-Carvalho; Gerzia C Machado; Eduardo Caio Torres-Santos; Aurea Echevarria
Journal:  Biomolecules       Date:  2019-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.